JPY 211.0
(-0.47%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 455.88 Million | -146.23 Million | 51.27 Million | 232.42 Million | 240.81 Million | -23.92 Million |
Net Income | -273.17 Million | -198.95 Million | -115.74 Million | -114.2 Million | -98.07 Million | 128.4 Million |
Depreciation & Amortization | 205.79 Million | 150.44 Million | 180.62 Million | 177.87 Million | 158.96 Million | 189.37 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 477.16 Million | -103.48 Million | 30.21 Million | 168.77 Million | 135.7 Million | 448.96 Million |
Other non-cash items | 847.77 Million | 5.75 Million | -43.81 Million | -17 Thousand | 44.21 Million | -790.67 Million |
Investing Cash Flow | -226.7 Million | -228.19 Million | -179.23 Million | -166.6 Million | -171.37 Million | 1.28 Billion |
Investments in PPE | -219.05 Million | -235.81 Million | -180.6 Million | -172.91 Million | -170.7 Million | -191.37 Million |
Acquisitions | 41 Thousand | - | -172 Million | -162.77 Million | - | 1.47 Billion |
Investment purchases | -7.69 Million | - | -260 Thousand | -2.54 Million | -2.55 Million | -2.49 Million |
Sales/Maturities of investments | - | - | 3.68 Million | 6.95 Million | - | -1.47 Billion |
Other Investing Activities | -219 Million | 7.62 Million | 169.95 Million | 164.67 Million | 1.88 Million | 1.47 Billion |
Financing Cash Flow | 75.34 Million | -215.65 Million | -258.04 Million | -164.18 Million | -445.42 Million | -89.71 Million |
Debt repayment | -75.34 Million | -215.65 Million | -543.77 Million | -379.42 Million | -445.42 Million | -489.71 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -1000.00 | -215 Million | 285.72 Million | 215.23 Million | -445 Million | 400 Million |
Accounts receivables | 14.02 Million | -51 Million | 244 Million | 121 Million | 257 Million | 572 Million |
Accounts payables | 53.01 Million | -56.88 Million | 19.5 Million | 52.65 Million | -232.77 Million | -210.91 Million |
Inventory | -457.12 Million | 81.49 Million | -150.07 Million | 36.85 Million | 67.05 Million | 165.27 Million |
Other working capital | 867.25 Million | -77.09 Million | -83.21 Million | -41.73 Million | 44.42 Million | -77.39 Million |
Cash at beginning of period | 817.54 Million | 1.38 Billion | 1.74 Billion | 1.84 Billion | 2.22 Billion | 1.06 Billion |
Cash at end of period | 1.12 Billion | 817.54 Million | 1.38 Billion | 1.74 Billion | 1.84 Billion | 2.22 Billion |
Capital Expenditure | -219.05 Million | -235.81 Million | -180.6 Million | -172.91 Million | -170.7 Million | -191.37 Million |
Effect of forex changes on cash | 4.67 Million | 25.98 Million | 22.2 Million | -161 Thousand | -8.57 Million | -9.75 Million |
Net cash flow / Change in cash | 309.19 Million | -564.09 Million | -363.79 Million | -98.52 Million | -384.56 Million | 1.16 Billion |
Free Cash Flow | 236.82 Million | -382.04 Million | -129.32 Million | 59.51 Million | 70.1 Million | -215.29 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 34 Million | -32 Million | -273.17 Million | -85 Million | -76 Million | -80 Million |
Depreciation & Amortization | - | - | 205.79 Million | 46.91 Million | 48.89 Million | 43.68 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 477.16 Million | - | - | - |
Other non-cash items | -34 Million | 32 Million | 847.77 Million | 85 Million | 76 Million | 80 Million |
Investing Cash Flow | - | - | -226.7 Million | - | - | - |
Investments in PPE | - | - | -219.05 Million | - | - | - |
Acquisitions | - | - | 41 Thousand | - | - | - |
Investment purchases | - | - | -7.69 Million | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | -219 Million | - | - | - |
Financing Cash Flow | - | - | 75.34 Million | - | - | - |
Debt repayment | - | - | -75.34 Million | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -1000.00 | - | - | - |
Accounts receivables | - | - | 14.02 Million | - | - | - |
Accounts payables | - | - | 53.01 Million | - | - | - |
Inventory | - | - | -457.12 Million | - | - | - |
Other working capital | - | - | 867.25 Million | - | - | - |
Cash at beginning of period | - | - | 817.54 Million | 830.33 Million | 1.06 Billion | 817.54 Million |
Cash at end of period | - | - | 1.12 Billion | 677.91 Million | 830.33 Million | 1.06 Billion |
Capital Expenditure | - | - | -219.05 Million | - | - | - |
Effect of forex changes on cash | - | - | 4.67 Million | - | - | - |
Net cash flow / Change in cash | - | - | 309.19 Million | -152.42 Million | -239.11 Million | 251.9 Million |
Free Cash Flow | - | - | 236.82 Million | 93.83 Million | 97.79 Million | 87.36 Million |
IRIS
7438
ULTA
EXPLEOSOL
SOFW
DELT